Dyskinesia
35 drugs23,035 FAERS reportsMedDRA PT
GET
/api/v1/reaction/dyskinesiaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D020820
Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.
Source: U.S. National Library of Medicine — MeSH (Dyskinesias)
Drugs reporting Dyskinesia (35)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Cystine133%
- 2Eladocagene Exuparvovec133%
- 3Opicapone27713%
- 4Safinamide14011%
- 5Entacapone49611%
- 6Mecamylamine110%
- 7Istradefylline4798.2%
- 8Apomorphine1277.6%
- 9Tolcapone267.6%
- 10Rasagiline7466.9%
- 11Deutetrabenazine4316.3%
- 12Amantadine1,2506.3%
- 13Asenapine5316.2%
- 14Levodopa3,5576.1%
- 15Carbidopa3,1076.0%
- 16Amcinonide56.0%
- 17Fluphenazine295.5%
- 18Selegiline1765.1%
- 19Rotigotine6434.6%
- 20Bicisate14.3%
- 21Ziprasidone8554.3%
- 22Metoclopramide3,2214.2%
- 23Pramipexole7894.1%
- 24Lurasidone8254.0%
- 25Trimethobenzamide523.7%
- 26Iloperidone513.7%
- 27Tiagabine33.7%
- 28Valbenazine8443.4%
- 29Thiothixene73.2%
- 30Ropinirole5733.1%
- 31Tetrabenazine2233.1%
- 32Silver Nitrate212.8%
- 33Aripiprazole2,4132.0%
- 34Paliperidone9821.9%
- 35Cariprazine1521.7%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
Literature
Recent PubMed references pinned to Dyskinesias as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Long-Term Surgical Outcomes and Influential Factors of Subthalamic Nucleus Deep Brain Stimulation for Dyskinesia in Parkinson's Disease: A 3-Year Longitudinal Cohort Study.Clinical interventions in aging · 2026 · Wang S, Xue T, Ma R, et al.PMID 42205153DOI 10.2147/CIA.S600031
- Aromatic-Turmerone Analogs Activate Chaperone-Mediated Autophagy and Ameliorate Dendritic Shrinkage in Purkinje Cell Models of Spinocerebellar Ataxia.Biological & pharmaceutical bulletin · 2026 · Motomura K, Ueda-Ishizaka E, Boateng A, et al.PMID 42203458DOI 10.1248/bpb.b26-00103
- Molecular features of a Huntington's disease knock-in minipig.Disease models & mechanisms · 2026 · Kolesnikova A, Sathasivam K, Tusi SK, et al.PMID 42186428DOI 10.1242/dmm.052803
- DNA methylation profiling in Huntington's disease reveals disease associated changes in the striatum.Clinical epigenetics · 2026 · Wheildon G, Smith AR, Weymouth L, et al.PMID 42185880DOI 10.1186/s13148-026-02082-4
- Intermittent Theta-Burst Stimulation (iTBS) Improves Motor Coordination and Modulates Neuroinflammation and Autophagy in SCA3/MJD Mice.Cerebellum (London, England) · 2026 · Chen LW, Lian YH, Dong XL, et al.PMID 42183960DOI 10.1007/s12311-026-02027-w
- The pathological Huntingtin CAG triplet expansion differentially affects the diagnosis of systemic and organ-specific autoimmune diseases.Frontiers in immunology · 2026 · Heyd M, Landwehrmeyer GB, Lewerenz J, et al.PMID 42183198DOI 10.3389/fimmu.2026.1689962
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.